Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the Apc Min /+ mouse model
The biological activities of chemokine (C-C motif) ligand 2 (CCL2) are mediated via C-C chemokine receptor-2 (CCR2). Increased CCL2 level is associated with metastasis of many cancers. In our study, we investigated the role of the CCL2/CCR2 axis in the development of spontaneous intestinal tumorigen...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 2021-05, Vol.148 (10), p.2594-2607 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The biological activities of chemokine (C-C motif) ligand 2 (CCL2) are mediated via C-C chemokine receptor-2 (CCR2). Increased CCL2 level is associated with metastasis of many cancers. In our study, we investigated the role of the CCL2/CCR2 axis in the development of spontaneous intestinal tumorigenesis using the Apc
mouse model. Ablation of CCR2 in Apc
mice significantly increased the overall survival and reduced intestinal tumor burden. Immune cell analysis showed that CCR2
Apc
mice exhibited significant reduction in the myeloid cell population and increased interferon γ (IFN-γ) producing T cells both in spleen and mesenteric lymph nodes compared to Apc
mice. The CCR2
Apc
tumors showed significantly reduced levels of interleukin (IL)-17 and IL-23 and increased IFN-γ and Granzyme B compared to Apc
tumors. Transfer of CCR2
Apc
CD4
T cells into Rag2
mice led to development of colitis phenotype with increased CD4
T cells hyper proliferation and IL-17 production. In contrast, adoptive transfer of CCR2
Apc
CD4
T cells into Rag2
mice failed to enhance colonic inflammation or IL-17 production. These results a suggest novel additional role for CCR2, where it regulates migration of IL-17 producing cells mediating tumor-promoting inflammation in addition to its role in migration of tumor associated macrophages. |
---|---|
ISSN: | 0020-7136 1097-0215 |
DOI: | 10.1002/ijc.33477 |